Search

everythinglearnresearchcommunity

for

Search:↓

Deleting the CD271 gene in mouse skin cells leads to disorganized skin and increased hair growth, suggesting CD271 is important for skin health.

The Walleye dermal sarcoma virus cyclin causes excessive skin cell growth in mice.

Human basal cell carcinomas and squamous cell carcinomas have unique gene expression patterns not fully mirrored in mouse models.

Catalase in processed meats may increase cancer risk due to electromagnetic emissions.

Vitamin D may help protect against nonmelanoma skin cancer.

A new topical treatment may prevent hair loss from cancer therapy by adjusting cell death processes in hair follicles.

Keratins are crucial for tissue strength, and mutations in keratin genes can lead to various diseases, highlighting the need for targeted therapies.

Basal cell carcinoma mostly starts from cells in the upper skin layers, not hair follicle stem cells.

Temporary activation of β-catenin can create new hair follicles, but ongoing activation is needed to keep hair follicle tumors.

Bone marrow-derived cells contribute to skin tumors, suggesting new treatment targets for non-melanoma skin cancers.

ERK activation spreads between cells, influencing cell division and wound healing.

Keratin 17 gene mutations cause both steatocystoma multiplex and pachyonychia congenita type 2.

Cholesterol and phospholipids increase in mouse skin during cancer development, with differences between male and female skin.

K6 gene expression can be controlled and manipulated in mice for studying skin disorders.

Lgr5+ stem cells do not cause skin tumors.

A specific DNA region controls skin cell gene expression by working with certain proteins.

The document concludes that the development of certain tumors is influenced by genetic background and that a specific gene modification can lead to tumor regression and reduced growth.

Mutations in specific keratin genes cause improper hair structure in mice due to faulty keratin protein assembly.

GLI2 activates GLI1, promoting skin tumor growth and hair development.

Lack of Crif1 in hair follicle stem cells slows down hair growth in mice.

The K5 promoter controls gene expression in skin cells, with specific DNA segments crucial for targeting and regulation.

Targeting ornithine decarboxylase can help prevent skin cancer.

The human K5 promoter controls specific gene expression in skin cells, with key regulatory elements near the TATA box.

A new genetic mutation linked to CARASIL syndrome and small artery disease was found in a Chinese family.

Most U.S. keratinocyte carcinoma patients are older white males living in urban areas.

Complex basal cell carcinomas need personalized treatment due to unique genetic mutations.

AZD6244 treatment causes skin aging effects by depleting skin stem cells.

Increased ODC activity leads to skin tumors by recruiting stem cells, not by toxic byproducts.

EGFR-targeted cancer therapy can cause skin issues starting at hair follicles, leading to inflammation.

The Megsin-Cre transgene is a new tool for genetic manipulation in the skin and upper digestive tract.